company background image
STE

STERIS NYSE:STE Stock Report

Last Price

US$225.94

Market Cap

US$22.6b

7D

4.5%

1Y

18.6%

Updated

22 May, 2022

Data

Company Financials +
STE fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance1/6
Financial Health5/6
Dividends0/6

STE Stock Overview

STERIS plc provides infection prevention and other procedural products and services worldwide.

STERIS Competitors

Price History & Performance

Summary of all time highs, changes and price drops for STERIS
Historical stock prices
Current Share PriceUS$225.94
52 Week HighUS$255.93
52 Week LowUS$188.10
Beta0.66
1 Month Change-3.22%
3 Month Change-0.04%
1 Year Change18.58%
3 Year Change67.23%
5 Year Change193.05%
Change since IPO10,854.67%

Recent News & Updates

Shareholder Returns

STEUS Medical EquipmentUS Market
7D4.5%0.5%-2.7%
1Y18.6%-16.2%-12.9%

Return vs Industry: STE exceeded the US Medical Equipment industry which returned -16.2% over the past year.

Return vs Market: STE exceeded the US Market which returned -12.9% over the past year.

Price Volatility

Is STE's price volatile compared to industry and market?
STE volatility
STE Average Weekly Movement4.7%
Medical Equipment Industry Average Movement10.6%
Market Average Movement7.8%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market2.9%

Stable Share Price: STE is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: STE's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198513,000Dan Carestiohttps://www.steris.com

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

STERIS Fundamentals Summary

How do STERIS's earnings and revenue compare to its market cap?
STE fundamental statistics
Market CapUS$22.62b
Earnings (TTM)US$243.89m
Revenue (TTM)US$4.59b

92.8x

P/E Ratio

4.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
STE income statement (TTM)
RevenueUS$4.59b
Cost of RevenueUS$2.49b
Gross ProfitUS$2.10b
Other ExpensesUS$1.86b
EarningsUS$243.89m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)2.44
Gross Margin45.78%
Net Profit Margin5.32%
Debt/Equity Ratio45.0%

How did STE perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

68%

Payout Ratio

Does STE pay a reliable dividends?

See STE dividend history and benchmarks
When do you need to buy STE by to receive an upcoming dividend?
STERIS dividend dates
Ex Dividend DateJun 13 2022
Dividend Pay DateJun 28 2022
Days until Ex dividend21 days
Days until Dividend pay date36 days

Does STE pay a reliable dividends?

See STE dividend history and benchmarks

Valuation

Is STERIS undervalued compared to its fair value and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


92.76x

Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: STE ($225.94) is trading above our estimate of fair value ($142.13)

Significantly Below Fair Value: STE is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: STE is poor value based on its PE Ratio (92.8x) compared to the US Medical Equipment industry average (35.2x).

PE vs Market: STE is poor value based on its PE Ratio (92.8x) compared to the US market (15.2x).


Price to Earnings Growth Ratio

PEG Ratio: STE is poor value based on its PEG Ratio (5x)


Price to Book Ratio

PB vs Industry: STE is overvalued based on its PB Ratio (3.5x) compared to the US Medical Equipment industry average (2.4x).


Future Growth

How is STERIS forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


18.7%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: STE's forecast earnings growth (18.7% per year) is above the savings rate (1.9%).

Earnings vs Market: STE's earnings (18.7% per year) are forecast to grow faster than the US market (12.5% per year).

High Growth Earnings: STE's earnings are forecast to grow, but not significantly.

Revenue vs Market: STE's revenue (7.9% per year) is forecast to grow faster than the US market (7.8% per year).

High Growth Revenue: STE's revenue (7.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: STE's Return on Equity is forecast to be low in 3 years time (8.9%).


Past Performance

How has STERIS performed over the past 5 years?

Past Performance Score

1/6

Past Performance Score 1/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


11.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: STE has a large one-off loss of $82.8M impacting its March 31 2022 financial results.

Growing Profit Margin: STE's current net profit margins (5.3%) are lower than last year (12.8%).


Past Earnings Growth Analysis

Earnings Trend: STE's earnings have grown by 11% per year over the past 5 years.

Accelerating Growth: STE's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: STE had negative earnings growth (-38.6%) over the past year, making it difficult to compare to the Medical Equipment industry average (14.5%).


Return on Equity

High ROE: STE's Return on Equity (3.7%) is considered low.


Financial Health

How is STERIS's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: STE's short term assets ($1.9B) exceed its short term liabilities ($922.2M).

Long Term Liabilities: STE's short term assets ($1.9B) do not cover its long term liabilities ($4.0B).


Debt to Equity History and Analysis

Debt Level: STE's net debt to equity ratio (39.7%) is considered satisfactory.

Reducing Debt: STE's debt to equity ratio has reduced from 52.6% to 45% over the past 5 years.

Debt Coverage: STE's debt is well covered by operating cash flow (23.2%).

Interest Coverage: STE's interest payments on its debt are well covered by EBIT (7.1x coverage).


Balance Sheet


Dividend

What is STERIS current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


0.76%

Current Dividend Yield

Upcoming Dividend Payment

TodayMay 23 2022Ex Dividend DateJun 13 2022Dividend Pay DateJun 28 202215 days from Ex DividendBuy in the next 21 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: STE's dividend (0.76%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.58%).

High Dividend: STE's dividend (0.76%) is low compared to the top 25% of dividend payers in the US market (4.11%).


Stability and Growth of Payments

Stable Dividend: STE is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: STE is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Earnings Payout to Shareholders

Earnings Coverage: STE is not paying a notable dividend for the US market.


Cash Payout to Shareholders

Cash Flow Coverage: STE is not paying a notable dividend for the US market.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.8yrs

Average management tenure


CEO

Dan Carestio (48 yo)

0.83

Tenure

US$2,912,769

Compensation

Mr. Daniel A. Carestio, also known as Dan, serves as the Chief Executive Officer & President at STERIS plc since July 29, 2021. He had been Senior Vice President and Chief Operating Officer at STERIS plc s...


CEO Compensation Analysis

Compensation vs Market: Dan's total compensation ($USD2.91M) is below average for companies of similar size in the US market ($USD13.34M).

Compensation vs Earnings: Dan's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


Leadership Team

Experienced Management: STE's management team is considered experienced (2.8 years average tenure).


Board Members

Experienced Board: STE's board of directors are considered experienced (6.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.3%.


Top Shareholders

Company Information

STERIS plc's employee growth, exchange listings and data sources


Key Information

  • Name: STERIS plc
  • Ticker: STE
  • Exchange: NYSE
  • Founded: 1985
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: US$22.623b
  • Shares outstanding: 100.13m
  • Website: https://www.steris.com

Number of Employees


Location

  • STERIS plc
  • 70 Sir John Rogerson’s Quay
  • Dublin 2
  • Dublin
  • Co. Dublin
  • D02 R296
  • Ireland

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/22 00:00
End of Day Share Price2022/05/20 00:00
Earnings2022/03/31
Annual Earnings2022/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.